| Name | Title | Contact Details |
|---|
For nearly 30 years, Press Ganey`s mission has been to support health care providers in understanding and improving the entire patient experience. As a strategic business partner to more than 10,000 health care organizations across the country and across the continuum of care, we are the leader in helping create continuous, sustainable improvement. Headquartered in South Bend, Indiana, Press Ganey serves clients nationwide with locally based teams of associates to ensure strong client connections and relationships. As a result, Press Ganey is acutely aware of the challenges and opportunities unique to specific providers and their communities. Our associates are professionals, deeply rooted in health care and strongly committed to our clients` success. Whether it`s in the hospital, medical practice, ambulatory or home care setting, we partner with clients to create and sustain a high-performance environment to ultimately improve the patient experience. Our comprehensive suite of health care solutions helps clients meet their goals of improved quality, better care and lower costs. Press Ganey provides both ongoing advisory services and consulting in all phases of performance improvement. Our patient experience advisors are uniquely trained and skilled to identify areas of opportunity and help clients implement targeted improvement plans. Our consultants, whose health care experience is a true differentiator, work in partnership with organizations to identify and implement best practices across their operations. Simply put, we are vested in our clients` success, and dedicated to helping understand and improve every dimension of the patient experience.
Nexeon MedSystems is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
ACU is a nonprofit, transdisciplinary organization of clinicians, advocates and health care organizations united in a common mission to improve the health of America`s underserved populations and to enhance the development and support of the health care clinicians serving these populations.
Vantage Outsourcing is a Effingham, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.